How Can You Support Your Child's Growth with Advanced Stem Cell Treatments for Autism

At Swiss Medica, we use donor mesenchymal stem cells derived from umbilical cord tissue. They are ethically sourced after healthy births, without the use of embryonic cells.

Umbilical cord-derived MSCs are generally well tolerated and have a lower risk of immune rejection. Their anti-inflammatory and immune-modulating properties may help support children with autism, where neuroinflammation can play a role.

Your child’s safety and well-being come first at Swiss Medica.

MSC therapy has been widely studied for safety, and we share the latest research at the end of this page. Each child receives an individually calculated dose based on their needs and body weight.

Our MSCs come from umbilical cords and placentas donated after healthy births. They are collected in sterile conditions from carefully screened donors and tested for bacterial, fungal, and viral contamination, as well as genetic stability and cell viability.

The stem cell transplantation procedure for children is designed to be as gentle and comfortable as possible. Stem cells are typically administered through intravenous infusions, which are generally well-tolerated.

Some children might experience mild discomfort at the injection site, similar to what one might feel after a routine vaccination. This discomfort is usually brief and resolves quickly. We are committed to making the experience as smooth and minimally uncomfortable as possible for your child.

Our doctors have many years of experience working with children, including those who may feel anxious in medical settings. The procedure is carried out calmly, in the presence of a parent, and feels similar to routine clinic procedures such as blood sampling or an IV drip.

The medical team monitors your child’s condition throughout the procedure and can adjust the pace or provide additional support if your child feels nervous.

After the introduction of cells, a skin rash may occur, which can be regarded as an allergic reaction in some cases. We monitor each child closely to ensure their safety throughout the therapy.

Stem cell therapy does not have any long-term side effects.

Most children tolerate therapy well. Potential reactions are generally mild and may include fever, headache, chills, a rash, or localized swelling and redness at the injection site. Occasionally, there may be increased activity following the therapy. These effects are typically temporary and can often be managed with pain relief or rest, resolving within a short time.

Our ASD treatment program is generally available for children aged 3 and older. Children between 3 and 7 years old—and in some cases up to 10—often respond best to therapy.

For children under 3, exosome-only programs may be considered and are discussed individually with the doctor.

Results are individual and usually develop gradually. First changes may appear within 1.5–3 months, sometimes earlier, such as calmer mood or better sleep.

The strongest effect is often seen within 3–6 months, with progress possible for up to 12 months. Stem cell therapy works as a supportive treatment alongside traditional developmental therapies and may create a window of opportunity for faster learning. During this period, it is especially important to continue speech therapy, occupational therapy, behavioral therapy, and home-based exercises.

Possible contraindications include active oncology, acute infections, mental disorders, and individual characteristics such as age or body weight. However, doctors evaluate the medical history and individual suitability to decide on the therapy's safety and efficacy for each patient.